Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial
Year: 2026
Type: article
Abstract: PURPOSE: Opioid-free anaesthesia (OFA) is increasingly used to limit intraoperative opioids in oncological surgery, but evidence in radical prostatectomy is scarce. We compared OFA with a remifentanil-based technique in laparoscopic radical prostatectomy (LRP) on a uniform multimodal and regional analgesic background. METHODS: Adult men undergoing LRP were randomized to OFA (dexmedetomidine plus ketamine, no intraoperative opioids) or a remifentanil-based technique. Both groups received identical multimodal premedication, bilateral quadratus lumborum block, sevoflurane maintenance and identical oxycodone patient-controlled analgesia (PCA). The primary outcome was total oxycodone consumption over the first 24 postoperative hours. Pre-specified secondary outcomes included Numeric Rating Scale (NRS) pain scores, postoperative nausea and vomiting (PONV), serum creatinine change to day 1, and the demanded-to-delivered PCA bolus ratio. RESULTS: Fifty-seven patients were analysed (OFA n = 32; remifentanil n = 25). Total 24-h oxycodone consumption did not differ (location-shift estimate - 2.0 mg, 95% CI -8.0 to 6.0; p = 0.556), and neither NRS scores nor PONV differed significantly. The demanded-to-delivered PCA bolus ratio was lower with OFA (location-shift estimate - 0.20, 95% CI -0.267 to 0.000; p = 0.006), as was the early rise in serum creatinine (location-shift estimate - 7.7 µmol/L, 95% CI -13.9 to -1.1; p = 0.034). Intraoperative bradycardia and hypotension did not differ significantly. CONCLUSION: In LRP, no statistically significant difference in 24-hour oxycodone consumption or pain scores was detected between OFA and remifentanil-based anaesthesia. The trial was not designed or powered for equivalence or non-inferiority, and these findings therefore do not establish comparable efficacy. Differences in two pre-specified secondary outcomes (a lower demanded-to-delivered PCA ratio and a smaller early creatinine rise) are hypothesis-generating. Because recruitment was curtailed, findings require confirmation in adequately powered trials, ideally in robot-assisted prostatectomy. TRIAL REGISTRATION: ClinicalTrials.gov NCT06380244, registered 23 April 2024.
Source: World Journal of Urology
Institution: Jagiellonian University
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Keywords: opioid-free anesthesia, laparoscopic radical prostatectomy, remifentanil, dexmedetomidine, ketamine, multimodal analgesia, quadratus lumborum block, patient-controlled analgesia, oxycodone consumption, postoperative pain, postoperative nausea and vomiting, serum creatinine, opioid-sparing anesthesia, prostate cancer surgery, regional anesthesia
Open Access status: hybrid
Estimated APC paid: $4,390
OpenAlex ID: W7235261902
